[1]
Kirsch, B., Dubois, J., Zaiac, M., Ahuja, S. and Chadha, D. 2020. A Multi-Center, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children/Adolescents, 9-16 Years, with Primary Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s116. DOI:https://doi.org/10.25251/skin.4.supp.116.